Evidence map›Paper›PMID 32377290›Full record

ReviewOxidative medicine and cellular longevity2020

Coumarins as Modulators of the Keap1/Nrf2/ARE Signaling Pathway.

Emad H M Hassanein, Ahmed M Sayed, Omnia E Hussein, Ayman M Mahmoud

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 1 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 1 synthesis or guideline pooled it, 241 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Coumarins in hypertension management: from vascular signaling pathways to clinical perspectives.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Extract ofInternational journal of molecular sciences · 2025
    Article
  18. Review
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Emad H M HassaneinDepartment of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University-Assiut Branch, Egypt.
Ahmed M SayedBiochemistry Laboratory, Chemistry Department, Faculty of Science, Assiut University, Egypt.
Omnia E HusseinPhysiology Division, Zoology Department, Faculty of Science, Beni-Suef University, Egypt.
Ayman M MahmoudPhysiology Division, Zoology Department, Faculty of Science, Beni-Suef University, Egypt.ORCID https://orcid.org/0000-0003-0279-6500
Beni-Suef University · EGAl-Azhar University · EGAssiut University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Keap1/Nrf2/ARE system is a central defensive mechanism against oxidative stress which plays a key role in the pathogenesis and progression of many diseases. Nrf2 is a redox-sensitive transcription factor controlling a variety of downstream antioxidant and cytodefensive genes. Nrf2 has a powerful anti-inflammatory activity mediated via modulating NF-

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalAntioxidant Response ElementsAntioxidantsCoumarinsHumansKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Signal TransductionAnti-Inflammatory Agents, Non-SteroidalAntioxidantsCoumarinsKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2

Identifiers

PMID32377290
PMCPMC7196981
OpenAlexW3018821257

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.